Sagent Pharmaceuticals (SGNT)

Add to Watchlists
Create an Alert
21.06 +0.16  +0.77% NASDAQ Apr 16, 8:00PM BATS Real time Currency in USD
View Full Chart
SGNT Price Chart
View All Events

SGNT Events

Date Type Description
Feb 11 Misc Sagent Pharmaceuticals Co Q4 2013 Earnings Conference Call
Feb 11 Earnings Sagent Pharmaceuticals Co Q4 2013 Earnings Results. Estimate: -0.01.
Nov 05 Misc Sagent Pharmaceuticals Sets Date and Time for Release of Third Quarter 2013 Financial Results
Nov 05 Earnings Sagent Pharmaceuticals Sets Date and Time for Release of Third Quarter 2013 Financial Results. Estimate: -0.03.
Aug 06 Misc Sagent Pharmaceuticals Sets Date and Time for Release of seCond Quarter 2013 Financial Results
Aug 06 Earnings Sagent Pharmaceuticals Sets Date and Time for Release of Second Quarter 2013 Financial Results. Estimate: -0.03.
Jun 13 Misc AGM Event for Sagent Pharmaceuticals Inc
May 06 Misc Sagent Pharmaceuticals Co First Quarter Earnings Conference Call
May 06 Earnings Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2013 Financial Results. Estimate: -0.02.
View All Performance Charts

SGNT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sagent Pharmaceuticals is up 23.34% over the last year vs S&P 500 Total Return up 22.52%, Sucampo Pharmaceuticals up 1.16%, and Jazz Pharmaceuticals up 157.8%.

Get Quote for

PDF Report for SGNT

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download SGNT Pro Report PDF
Advertisement

Portfolio Strategies Featuring SGNT

Did Sagent Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SGNT Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Illinois
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Sagent Pharmaceuticals Co is engaged in the developing, manufacturing, sourcing and marketing injectable pharmaceutical products, which it sells primarily in the United States of America.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SGNT 21.06 +0.16 +0.77% 669.60M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.